Pluristem Therapeutics Inc.
(NASDAQ : PSTI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.04%202.801.2%$540.41m
GILDGilead Sciences, Inc.
-0.43%73.850.9%$464.36m
BIIBBiogen Inc.
-2.08%323.271.3%$369.76m
CELGCelgene Corporation
0.19%83.111.2%$338.92m
ILMNIllumina, Inc.
-1.35%317.103.5%$321.80m
REGNRegeneron Pharmaceuticals, Inc.
-0.34%393.902.6%$236.69m
VRTXVertex Pharmaceuticals Incorporated
-0.64%177.761.9%$224.13m
ALXNAlexion Pharmaceuticals, Inc.
0.43%127.102.0%$221.29m
SRPTSarepta Therapeutics, Inc.
-1.61%136.5616.4%$172.25m
AAgilent Technologies, Inc.
-1.61%64.691.5%$156.20m
BMRNBioMarin Pharmaceutical Inc.
0.17%104.004.4%$143.34m
LGNDLigand Pharmaceuticals Incorporated
-2.66%191.8123.3%$115.50m
NKTRNektar Therapeutics
-0.42%49.355.6%$104.89m
EXASExact Sciences Corporation
-0.85%62.9325.3%$103.72m
NBIXNeurocrine Biosciences, Inc.
-0.54%113.965.1%$99.57m

Company Profile

Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.